Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
Author:
Funder
National Cancer Institute
National Science Foundation
Department of Defense
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference44 articles.
1. Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms;Carbone;Clin. Lung Cancer,2011
2. The current status of targeted therapy for non-small cell lung cancer;Francis;Intern. Med. J.,2010
3. Chemotherapy for lung cancer: the state of the art in 2009;Higgins;Expert. Rev. Anticancer. Ther.,2009
4. Recent advances of novel targeted therapy in non-small cell lung cancer;Katzel;J. Hematol. Oncol.,2009
5. The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC);Wagner;Curr. Drug Targets,2010
Cited by 346 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23
2. Lipid- and Protein-based Nanodelivery Systems;Functional Materials from Lipids and Proteins;2024-08-23
3. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood–brain-barrier and glioblastoma stem cells;Biomedical Materials;2024-08-22
4. Membrane fusion-based drug delivery liposomes transiently modify the material properties of synthetic and biological membranes;2024-08-15
5. Targeted Lipid-Based Drug Delivery Systems for Lung Cancer Therapy;Applied Sciences;2024-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3